• ADiTx received a Nasdaq staff delisting determination on May 6, 2026, citing non-compliance with Nasdaq Listing Rule 5550(a)(2) after its bid price closed below USD 1 for 30 consecutive business days from March 24, 2026 through May 5, 2026.
• Nasdaq staff said ADiTx is not eligible for a standard 180-day cure period under Rule 5810(c)(3)(A)(iv), citing reverse stock splits within the past year and a cumulative reverse-split ratio of 250-to-1 or more over the past two years.
• ADiTx plans to request a Nasdaq hearings panel review, which would stay delisting while the appeal is pending.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ADiTx Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-053904), on May 08, 2026, and is solely responsible for the information contained therein.